Overview Sturge-Weber Syndrome (SWS) is a vascular disorder of capillary angiomas resulting in port wine stain angiomas affecting the skin, angiomas and glaucoma of the eye, and leptomeningeal angiomas surrounding the brain. SWS patients with brain involvement can have seizures, stroke-like episodes, and neurologic deficits. Current treatments used to prevent these symptoms include aspirin and anti-seizure medications, but neither is well supported by longitudinal studies. Nor is it clear exactly what causes stroke-like symptoms or how to identify SWS patients at risk for these symptoms. The overall objective of this study is to identify SWS patients at most risk to have severe neurological symptoms and to identify potential treatments. We are conducting a multi-center, longitudinal study, and collecting detailed clinical and imaging data, as well as blood samples at three time points from patients. For more information about the study For more information about SWSTo request a clinic appointment at the UCSF Birthmarks and Vascular Anomalies Center Affiliated Lab Center for Cerebrovascular Research Principal investigator UCSF Helen Kim, MPH, PhD Professor in Residence External persons Jeffrey Loeb, MD, PhD Professor and Head, Dept of Neurology and Rehabilitation, University of Illinois at Chicago Collaborators External persons Ilona Frieden, MD Professor, Department of Clinical Dermatology and Pediatrics Director, UCSF Birthmarks and Vascular Anomalies Center Seeking collaborators Our project is looking for individuals to join our team. Get in touch if you’d like to learn more. Email Us Support this research Are you excited by the innovative work we’re doing on this project? Learn how your financial support can make the difference in our work. Support
Center for Cerebrovascular Research Cellular loci involved in the pathogenesis of brain arteriovenous malformations
Center for Cerebrovascular Research Detection of somatic mutations in cerebral cavernous malformation patients using non-invasive cell-free DNA screening
Center for Cerebrovascular Research Reduction of brain AVM severity through inhibition of pathogenic angiogenesis
Center for Cerebrovascular Research IL-6 trans-signaling increases risk for perioperative neurocognitive disorders in aging and neurodegenerative diseases
Center for Cerebrovascular Research Cerebral hemorrhage risk in hereditary hemorrhagic telangiectasia (BVMC 6203)
Center for Cerebrovascular Research Biomarkers of Cerebral Cavernous Angioma with Symptomatic Hemorrhage (CASH)
Center for Cerebrovascular Research Predictors of growth, recurrence, and high-risk features in pediatric brain arteriovenous malformation (project 1)
Center for Cerebrovascular Research Epigenetic signatures and association with hemorrhage and high risk features in brain arteriovenous malformation
Center for Cerebrovascular Research Modifiers of disease severity and progression in familial cerebral cavernous malformation (BVMC 6201)
Center for Cerebrovascular Research Investigating disparities and barriers in access to research and care for patients with Hereditary Hemorrhagic Telangiectasia (HHT)
